Logo

BforCure Gets CE-IVD Mark for Molecular SARS-CoV-2 Test Kit

Nov 10, 2021 | staff reporter

NEW YORK — BforCure said last week that it has received CE-IVD marking for its Bfast SARS-CoV-2 RT-PCT kit.

The kit is designed to detect two SARS-CoV-2 genes. It runs on the company's Chronos Dx in vitro diagnostic PCR platform and provides results within 15 minutes.

Last month, Paris-based BforCure raised €2 million ($2.3 million) from ID-Solutions to adapt Chronos Dx to detect cancers.

Filed under

Molecular Diagnostics
Infectious Disease
COVID-19
PCR
Regulatory News & FDA Approvals
Business News
CE mark
Europe
Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.